Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$770M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$580M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$391M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$322M |
| 5 |
UnitedHealth
UNH
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.21B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$351M |
| 3 |
RP
RealPage, Inc.
RP
|
+$316M |
| 4 |
Shopify
SHOP
|
+$312M |
| 5 |
Boeing
BA
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.82% |
| 2 | Healthcare | 7.16% |
| 3 | Financials | 5.78% |
| 4 | Consumer Discretionary | 5.64% |
| 5 | Industrials | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Savara
SVRA
$1.12B
| $3.32M | ﹤0.01% |
1,954,814
+1,455,448
| +291% | +$2.62M |
|
3277
Perrigo
PRGO
$1.4B
| $3.32M | ﹤0.01% |
72,369
-785,841
| -92% | -$34.8M |
|
3278
CALL
Transmedics
TMDX
$2.64B
| $3.32M | ﹤0.01% |
+100,000
| New | +$2.77M |
|
|
IBER.U
3279
DELISTED
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
| $3.32M | ﹤0.01% |
330,118
-194,882
| -37% | -$1.95M |
|
3280
SAP
SAP
$212B
| $3.32M | ﹤0.01% |
23,607
+16,453
| +230% | +$2.29M |
|
|
NVRO
3281
CALL
DELISTED
NEVRO CORP.
NVRO
| $3.32M | ﹤0.01% |
+20,000
| New | +$3.12M |
|
|
HMHC
3282
PUT
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $3.31M | ﹤0.01% |
300,000
| – | – |
|
|
AERI
3283
DELISTED
Aerie Pharmaceuticals
AERI
| $3.31M | ﹤0.01% |
206,598
+131,748
| +176% | +$2.26M |
|
3284
Hamilton Lane
HLNE
$4.91B
| $3.3M | ﹤0.01% |
+36,216
| New | +$3.28M |
|
3285
Arrow Electronics
ARW
$11.1B
| $3.3M | ﹤0.01% |
28,969
+13,172
| +83% | +$1.54M |
|
3286
Gilat Satellite Networks
GILT
$834M
| $3.3M | ﹤0.01% |
323,921
-18,778
| -5% | -$187K |
|
|
GOCO
3287
DELISTED
GoHealth
GOCO
| $3.29M | ﹤0.01% |
19,541
-112,697
| -85% | -$19.7M |
|
3288
CALL
Idexx Laboratories
IDXX
$44.1B
| $3.28M | ﹤0.01% |
5,200
-1,300
| -20% | -$718K |
|
|
BHIL
3289
DELISTED
Benson Hill, Inc.
BHIL
| $3.28M | ﹤0.01% |
9,475
+8,348
| +741% | +$2.93M |
|
3290
Ciena
CIEN
$53.4B
| $3.28M | ﹤0.01% |
57,649
+40,999
| +246% | +$2.26M |
|
3291
CALL
Seer Inc
SEER
$122M
| $3.28M | ﹤0.01% |
+100,000
| New | +$3.94M |
|
3292
Delek US
DK
$4.16B
| $3.27M | ﹤0.01% |
151,393
+139,164
| +1,138% | +$3.14M |
|
3293
iShares National Muni Bond ETF
MUB
$45.1B
| $3.26M | ﹤0.01% |
27,847
+23,772
| +583% | +$2.78M |
|
|
TLMDW
3294
CALL
DELISTED
SOC Telemed, Inc. Warrants
TLMDW
| $3.26M | ﹤0.01% |
3,328,800
+946,692
| +40% | +$1.03M |
|
|
PTICU
3295
DELISTED
PropTech Investment Corporation II Unit
PTICU
| $3.26M | ﹤0.01% |
325,000
-125,000
| -28% | -$1.26M |
|
3296
GoodRx Holdings
GDRX
$1.04B
| $3.24M | ﹤0.01% |
+90,040
| New | +$3.32M |
|
|
WNS
3297
DELISTED
WNS Holdings
WNS
| $3.24M | ﹤0.01% |
40,588
-120,732
| -75% | -$8.97M |
|
|
TMX
3298
DELISTED
Terminix Global Holdings, Inc.
TMX
| $3.24M | ﹤0.01% |
67,930
+54,812
| +418% | +$2.69M |
|
3299
NextCure
NXTC
$16.9M
| $3.24M | ﹤0.01% |
33,610
+26,102
| +348% | +$2.67M |
|
3300
CALL
Immunovant
IMVT
$7.93B
| $3.24M | ﹤0.01% |
+306,300
| New | +$4.28M |
|
Similar funds
Millennium Management's Q2 2021 Portfolio in Review
As of Q2 2021, Millennium Management held 7,530 positions worth $163B, up 17% from $140B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management deployed $13.3B of net new capital in Q2 2021, opening 1,693 new positions and adding to 2,343 existing holdings. Its largest new stake was SiteOne Landscape Supply: 609,104 shares worth $103M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, down from 8.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Apple, an estimated $1.21B trimmed.
- Millennium Management's largest Q2 2021 buy was SiteOne Landscape Supply: 609,104 shares worth $103M.
- Millennium Management added most to Linde in Q2 2021, an estimated $770M increase.
- Millennium Management's biggest Q2 2021 reduction was Apple, cutting an estimated $1.21B.
- Millennium Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $351M.
- Millennium Management's ten largest holdings make up 20% of its $163B portfolio in Q2 2021.
- Millennium Management opened 1,693 new positions and closed 1,074 in Q2 2021.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $163B.
Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.